Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '5-HT1A AGONISTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 101 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bourin, M; Fiocco, AJ; Clenet, F
      How valuable are animal models in defining antidepressant activity?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    2. Demeulemeester, H; Feys, H; Goris, I; Zwaenepoel, I; De Weerdt, W; De Sutter, P; Gybels, J; Plets, C; Nuttin, B
      Effect of the serotonin agonist 8-OH-DPAT on the sensorimotor system of the rat

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    3. Le Marec, N; Ase, AR; Botez-Marquard, T; Marchand, L; Reader, TA; Lalonde, R
      Behavioral and biochemical effects of L-tryptophan and buspirone in a model of cerebellar atrophy

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    4. Oshima, T; Kasuya, Y; Terazawa, E; Nagase, K; Saitoh, Y; Dohi, S
      The anxiolytic effects of the 5-hydroxytryptamine-1A agonist tandospirone before otolaryngologic surgery

      ANESTHESIA AND ANALGESIA
    5. Haller, J; Leveleki, C; Halasz, J; Baranyi, J; Makara, GB
      The effect of glucocorticoids on the anxiolytic efficacy of buspirone

      PSYCHOPHARMACOLOGY
    6. Groenink, L; Joordens, RJE; Hijzen, TH; Dirks, A; Olivier, B
      Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle

      NEUROREPORT
    7. Cervo, L; Munoz, C; Bertaglia, A; Samanin, R
      Alnespirone and buspirone have anxiolytic-like effects in a conflict procedure in rats by stimulating 5-HT1A receptors

      BEHAVIOURAL PHARMACOLOGY
    8. Kalsner, S
      The question of feedback at the somadendritic region and antidepressant drug action

      BRAIN RESEARCH BULLETIN
    9. Hascoet, M; Bourin, M; Dhonnchadha, BAN
      The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    10. Commissaris, RL; Ardayfio, PA; McQueen, DA; Gilchrist, GA; Overstreet, DH
      Conflict behavior and the effects of 8-OHDPAT treatment in rats selectively bred for differential 5-HT1A-induced hypothermia

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    11. Millan, MJ
      Improving the treatment of schizophrenia: Focus on serotonin (5-HT)(1A) receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    12. Millan, MJ; Brocco, M; Rivet, JM; Audinot, V; Newman-Tancredi, A; Maiofiss, L; Queriaux, S; Despaux, N; Peglion, JL; Dekeyne, A
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Mensonides-Harsema, MM; Liao, Y; Bottcher, H; Bartoszyk, GD; Greiner, HE; Harting, J; de Boer, P; Wikstrom, HV
      Synthesis and in vitro and in vivo functional studies of ortho-substitutedphenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Torup, L; Moller, A; Sager, TN; Diemer, NH
      Neuroprotective effect of 8-OH-DPAT in global cerebral ischemia assessed by stereological cell counting

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Tsuji, M; Takeda, H; Matsumiya, T
      Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test

      PSYCHOPHARMACOLOGY
    16. Chiang, TJ; Al-Ruwaitea, ASA; Mobini, S; Ho, MY; Bradshaw, CM; Szabadi, E
      Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules

      PSYCHOPHARMACOLOGY
    17. Demopoulos, VJ; Gavalas, A; Rekatas, GV; Tani, E; Soskic, V
      Activity on the CNS and antioxidant profile of two benzo[g]indolamine derivatives

      MEDICINAL CHEMISTRY RESEARCH
    18. Brambilla, A; Baschirotto, A; Grippa, N; Borsini, F
      Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    19. Mokrosz, MJ; Kowalski, P; Kowalska, T; Majka, Z; Duszynska, B; Bojarski, AJ; Fruzinski, A; Karolak-Wojciechowska, J; Wesolowska, A; Klodzinska, A; Tatarczynska, E; Chojnacka-Wojcik, E
      Structure-activity relationship studies of CNS agents. Part 38 - Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3-benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT1A and antagonistic 5-HT2A activities

      ARCHIV DER PHARMAZIE
    20. LAFLAMME N; FEUVRIER E; RICHARD D; RIVEST S
      INVOLVEMENT OF SEROTONERGIC PATHWAYS IN MEDIATING THE NEURONAL-ACTIVITY AND GENETIC TRANSCRIPTION OF NEUROENDOCRINE CORTICOTROPIN-RELEASINGFACTOR IN THE BRAIN OF SYSTEMICALLY ENDOTOXIN-CHALLENGED RATS

      Neuroscience
    21. Cryan, JF; Kelliher, P; Kelly, JP; Leonard, BE
      Comparative effects of serotonergic agonists with varying efficacy at the 5-HT1A receptor on core body temperature: modification by the selective 5-HT1A receptor antagonist WAY 100635

      JOURNAL OF PSYCHOPHARMACOLOGY
    22. Pawlowski, M; Katlabi, J; Drabczynska, A; Duszynska, B; Charakchieva-Minol, S; Deren-Wesolek, A; Tatarczynska, E; Chojnacka-Wojcik, E; Mokrosz, MJ; Bojarski, AJ
      New 9- or 10-arylpiperazinoalkyl substituted pyrimido- or diazepino[2,1-f]purines with partial or full 5-HT1A agonistic activity

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    23. Menard, J; Treit, D
      Effects of centrally administered anxiolytic compounds in animal models ofanxiety

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    24. Setem, J; Pinheiro, AP; Motta, VA; Morato, S; Cruz, APM
      Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

    25. NOVEL PIPERAZINE AND PIPERIDINE COMPOUNDS FOR SCHIZOPHRENIA

      Expert opinion on therapeutic patents
    26. MENARD J; TREIT D
      THE SEPTUM AND THE HIPPOCAMPUS DIFFERENTIALLY MEDIATE ANXIOLYTIC EFFECTS OF R(-8-OH-DPAT())

      Behavioural pharmacology
    27. BERTON O; AGUERRE S; SARRIEAU A; MORMEDE P; CHAOULOFF F
      DIFFERENTIAL-EFFECTS OF SOCIAL STRESS ON CENTRAL SEROTONERGIC ACTIVITY AND EMOTIONAL REACTIVITY IN LEWIS AND SPONTANEOUSLY HYPERTENSIVE RATS

      Neuroscience
    28. WU CF; LIU J; CONSOLO S; LIU W
      5-HT1A RECEPTORS MEDIATE INHIBITION OF ETHANOL-INDUCED ASCORBIC-ACID RELEASE IN RAT STRIATUM STUDIED BY MICRODIALYSIS

      Neuroscience letters
    29. LAPIERRE YD; SILVERSTONE P; REESAL RT; SAXENA B; TURNER P; BAKISH D; PLAMONDON J; VINCENT PM; REMICK RA; KROFT C; PAYEUR R; ROSALES D; LAM R; BOLOGA M
      A CANADIAN MULTICENTER STUDY OF 3 FIXED DOSES OF CONTROLLED-RELEASE IPSAPIRONE IN OUTPATIENTS WITH MODERATE TO SEVERE MAJOR DEPRESSION

      Journal of clinical psychopharmacology
    30. NAKAI K; FUJII T; FUJIMOTO K; SUZUKI T; KAWASHIMA K
      EFFECT OF WAY-100135 ON THE HIPPOCAMPAL ACETYLCHOLINE-RELEASE POTENTIATED BY 8-OH-DPAT, A SEROTONIN(1A) RECEPTOR AGONIST, IN NORMAL AND P-CHLOROPHENYLALANINE-TREATED RATS AS MEASURED BY IN-VIVO MICRODIALYSIS

      Neuroscience research
    31. De Almeida, RMM; Giovenardi, M; Charchat, H; Lucion, AB
      8-OH-DPAT in the median raphe nucleus decreases while in the medial septalarea it may increase anxiety in female rats

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    32. ELGANOUNI S; TAZI A; HAKKOU F
      POTENTIAL SEROTONERGIC INTERACTIONS WITH THE ANXIOLYTIC-LIKE EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS

      Pharmacology, biochemistry and behavior
    33. JIN YH; AKAIKE N
      TANDOSPIRONE-INDUCED K+ CURRENT IN ACUTELY DISSOCIATED RAT DORSAL RAPHE NEURONS

      British Journal of Pharmacology
    34. JORGENSEN H; KNIGGE U; KJAER A; VADSHOLT T; WARBERG J
      SEROTONERGIC INVOLVEMENT IN STRESS-INDUCED ACTH RELEASE

      Brain research
    35. REDROBE JP; BOURIN M
      DOSE-DEPENDENT INFLUENCE OF BUSPIRONE ON THE ACTIVITIES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE MOUSE FORCED SWIMMING TEST

      Psychopharmacology
    36. RODGERS RJ
      ANIMAL-MODELS OF ANXIETY - WHERE NEXT

      Behavioural pharmacology
    37. YU H; LEWANDER T
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF (R)-8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN IN THE RAT

      European neuropsychopharmacology
    38. EATON MJ; SANTIAGO DI; DANCAUSSE HA; WHITTEMORE SR
      LUMBAR TRANSPLANTS OF IMMORTALIZED SEROTONERGIC NEURONS ALLEVIATE CHRONIC NEUROPATHIC PAIN

      Pain
    39. HANSSON LO; ENNIS MD; STJERNLOF P
      QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS IN THE 8-AMINO-6,7,8,9-TETRAHYDRO-3H-BENZ[E]INDOLE RING-SYSTEM - ANALYSIS OF SEROTONIN 5-HT1AEFFECTS IN-VIVO AND IN-VITRO VIA PARTIAL LEAST-SQUARES REGRESSION

      European journal of medicinal chemistry
    40. GRIEBEL G; RODGERS RJ; PERRAULT G; SANGER DJ
      RISK ASSESSMENT BEHAVIOR - EVALUATION OF UTILITY IN THE STUDY OF 5-HT-RELATED DRUGS IN THE RAT ELEVATED PLUS-MAZE TEST

      Pharmacology, biochemistry and behavior
    41. DESOUZA AC; DESOUZA RLN; PELA IR; GRAEFF FG
      HIGH-INTENSITY SOCIAL-CONFLICT IN THE SWISS ALBINO MOUSE INDUCES ANALGESIA MODULATED BY 5-HT1A RECEPTORS

      Pharmacology, biochemistry and behavior
    42. CASANOVAS JM; LESOURD M; ARTIGAS F
      THE EFFECT OF THE SELECTIVE 5-HT1A AGONISTS ALNESPIRONE (S-20499) AND8-OH-DPAT ON EXTRACELLULAR 5-HYDROXYTRYPTAMINE IN DIFFERENT REGIONS OF RAT-BRAIN

      British Journal of Pharmacology
    43. SEALE TW; NIEKRASZ I; GARRETT KM
      ANXIOLYSIS BY ETHANOL, DIAZEPAM AND BUSPIRONE IN A NOVEL MURINE BEHAVIORAL ASSAY

      NeuroReport
    44. CAO BJ; RODGERS RJ
      DIFFERENT BEHAVIORAL PROFILES OF THE R(-ENANTIOMER AND S(-)-ENANTIOMER OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN IN THE MURINE ELEVATED PLUS-MAZE())

      Behavioural pharmacology
    45. BENVENGA MJ; LEANDER JD
      ANTICONFLICT EFFECTS OF 5HT(1A) AGONISTS IN PIGEONS ARE DEPENDENT ON THE LEVEL OF RESPONSE SUPPRESSION

      Behavioural pharmacology
    46. VANPRAAG HM
      FAULTY CORTISOL SEROTONIN INTERPLAY - PSYCHOPATHOLOGICAL AND BIOLOGICAL CHARACTERIZATION OF A NEW, HYPOTHETICAL DEPRESSION SUBTYPE (SECA DEPRESSION)/

      Psychiatry research
    47. LOPEZRUBALCAVA C
      PRESYNAPTIC OR POSTSYNAPTIC ACTIVITY OF 5-HT1A COMPOUNDS IN MICE DEPENDS ON THE ANXIETY PARADIGM

      Pharmacology, biochemistry and behavior
    48. ABE M; TABATA R; SAITO K; MATSUDA T; BABA A; EGAWA M
      NOVEL BENZODIOXAN DERIVATIVE, ODIOXAN-2-YLMETHYL)AMINO]PROPOXY)-1,3-BENZODIOXOLE HCL (MKC-242), WITH ANXIOLYTIC-LIKE AND ANTIDEPRESSANT-LIKE EFFECTS IN ANIMAL-MODELS

      The Journal of pharmacology and experimental therapeutics
    49. ALPER RH; SCHMITZ TM
      ESTROGEN INCREASES THE BRADYCARDIA ELICITED BY CENTRAL ADMINISTRATIONOF THE SEROTONIN(1A) AGONIST 8-OH-DPAT IN CONSCIOUS RATS

      Brain research
    50. NAKAGAWA Y; ISHIMA T; ISHIBASHI Y; YOSHII T; TAKASHIMA T
      INVOLVEMENT OF GABA(B) RECEPTOR SYSTEMS IN ACTION OF ANTIDEPRESSANTS - BACLOFEN BUT NOT BICUCULLINE ATTENUATES THE EFFECTS OF ANTIDEPRESSANTS ON THE FORCED SWIM TEST IN RATS

      Brain research
    51. STANHOPE KJ; DOURISH CT
      EFFECTS OF 5-HT1A RECEPTOR AGONISTS, PARTIAL AGONISTS AND A SILENT ANTAGONIST ON THE PERFORMANCE OF THE CONDITIONED EMOTIONAL RESPONSE TESTIN THE RAT

      Psychopharmacology
    52. POWELL KR; DYKSTRA LA
      THE ROLE OF SEROTONERGIC RECEPTORS IN THE EFFECTS OF MU-OPIOID IN SQUIRREL-MONKEYS RESPONDING UNDER A TITRATION PROCEDURE

      Psychopharmacology
    53. MOKROSZ JL; PALUCHOWSKA MH; KLODZINSKA A; CHARAKCHIEVAMINOL S; CHOJNACKAWOJCIK E
      STRUTURE-ACTIVITY RELATIONSHIP STUDIES OF CNS AGENTS .26. CARBOXAMIDO)ETHYL]-1-(2-METHOXYPHENYL)-PIPERAZINES - HIGH-AFFINITY 5-HT1A AGONISTS

      Archiv der pharmazie
    54. BERLIN I; CHALON S; PAYAN C; SCHOLLNHAMMER G; CESSELIN F; VAROQUAUX O; PUECH AJ
      EVALUATION OF THE ALPHA(2)-ADRENOCEPTOR BLOCKING PROPERTIES OF BUSPIRONE AND IPSAPIRONE IN HEALTHY-SUBJECTS - RELATIONSHIP WITH THE PLASMA-CONCENTRATION OF THE COMMON METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE

      British journal of clinical pharmacology
    55. HANDLEY SL
      5-HYDROXYTRYPTAMINE PATHWAYS IN ANXIETY AND ITS TREATMENT

      Pharmacology & therapeutics
    56. GRIEBEL G; BLANCHARD DC; JUNG A; MASUDA CK; BLANCHARD RJ
      5-HT1A AGONISTS MODULATE MOUSE ANTIPREDATOR DEFENSIVE BEHAVIOR DIFFERENTLY FROM THE 5-HT2A ANTAGONIST PIRENPERONE

      Pharmacology, biochemistry and behavior
    57. MUEHLENKAMP F; LUCION A; VOGEL WH
      EFFECTS OF SELECTIVE SEROTONERGIC AGONISTS ON AGGRESSIVE-BEHAVIOR IN RATS

      Pharmacology, biochemistry and behavior
    58. FERNANDEZGUASTI A; LOPEZRUBALCAVA C
      ACTION OF IPSAPIRONE AND 8-OH-DPAT ON EXPLORATORY-BEHAVIOR IN HAMSTERS (MESOCRICETUS-AURATUS) - EFFECTS OF ANTAGONISTS AND P-CPA

      Pharmacology, biochemistry and behavior
    59. NADAL RA; PALLARES MA; FERRE NS
      EFFECTS OF ETHANOL, CAFFEINE, AND CLORAZEPATE ON HYPERTONIC NACL SOLUTION INTAKE IN RATS

      Physiology & behavior
    60. BRUSS M; BUHLEN M; ERDMANN J; GOTHERT M; BONISCH H
      BINDING-PROPERTIES OF THE NATURALLY-OCCURRING HUMAN 5-HT1A RECEPTOR VARIANT WITH THE LLE28VAL SUBSTITUTION IN THE EXTRACELLULAR DOMAIN

      Naunyn-Schmiedeberg's archives of pharmacology
    61. CHEN NH; REITH MEA
      MONOAMINE INTERACTIONS MEASURED BY MICRODIALYSIS IN THE VENTRAL TEGMENTAL AREA OF RATS TREATED SYSTEMICALLY WITH (+ -)-8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN/

      Journal of neurochemistry
    62. FREO U; PIETRINI P; PIZZOLATO G; FUREYKURKJIAN M; MERICO A; RUGGERO S; DAM M; BATTISTIN L
      DOSE-DEPENDENT EFFECTS OF BUSPIRONE ON BEHAVIOR AND CEREBRAL GLUCOSE-METABOLISM IN RATS

      Brain research
    63. MORGAN D; PICKER MJ
      DISCRIMINATIVE STIMULUS EFFECTS OF THE 5HT(1A) AGONIST 8-OH-DPAT - ATTENUATION BY MU BUT NOT BY KAPPA-OPIOIDS

      Psychopharmacology
    64. DEVRY J
      5-HT1A RECEPTOR AGONISTS - RECENT DEVELOPMENTS AND CONTROVERSIAL ISSUES

      Psychopharmacology
    65. PROTAIS P; WINDSOR M; MOCAER E; COMOY E
      POST SYNAPTIC 5-HT1A RECEPTOR INVOLVEMENT IN YAWNING AND PENILE ERECTIONS INDUCED BY APOMORPHINE, PHYSOSTIGMINE AND MCPP IN RATS

      Psychopharmacology
    66. EVENDEN J; RYAN C; PALEJKO W
      THE EFFECTS OF REPEATED TREATMENT WITH 8 HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN (8-OH-DPAT) ON THE LEVER PRESS RESPONDING OF THE RAT UNDER FLAND DRL SCHEDULES OF FOOD REINFORCEMENT

      Psychopharmacology
    67. DETKE MJ; WIELAND S; LUCKI I
      BLOCKADE OF THE ANTIDEPRESSANT-LIKE EFFECTS OF 8-OH-DPAT, BUSPIRONE AND DESIPRAMINE IN THE RAT FORCED SWIM TEST BY 5HT(1A) RECEPTOR ANTAGONISTS

      Psychopharmacology
    68. GOUDIE AJ; LEATHLEY MJ; COWGILL J
      ASSESSMENT OF THE BENZODIAZEPINE-LIKE DEPENDENCE POTENTIAL IN RATS OFTHE PUTATIVE 5-HT1A AGONIST ANXIOLYTIC S-20499

      Behavioural pharmacology
    69. CHAOULOFF F
      FAILURE TO FIND BEHAVIORAL-DIFFERENCES BETWEEN LEAN AND OBESE ZUCKER RATS EXPOSED TO NOVEL ENVIRONMENTS

      International journal of obesity
    70. CHAOULOFF F
      FAILURE TO FIND BEHAVIORAL-DIFFERENCES BETWEEN LEAN AND OBESE ZUCKER RATS EXPOSED TO NOVEL ENVIRONMENTS

      International journal of obesity
    71. CUTLER NR; HESSELINK JMK; SRAMEK JJ
      A PHASE-II MULTICENTER DOSE-FINDING, EFFICACY AND SAFETY TRIAL OF IPSAPIRONE IN OUTPATIENTS WITH GENERALIZED ANXIETY DISORDER

      Progress in neuro-psychopharmacology & biological psychiatry
    72. GOUDIE AJ; LEATHLEY MJ
      ASSESSMENT OF THE DEPENDENCE POTENTIAL OF THE POTENT HIGH-EFFICACY 5-HT1A AGONIST S-14506 IN RATS

      JOURNAL OF PSYCHOPHARMACOLOGY
    73. HASCOET M; BOURIN M; TODD KG; DUTERTRE AC
      ANTICONFLICT EFFECT OF 5-HT1A AGONISTS IN RATS - A NEW MODEL FOR EVALUATING ANXIOLYTIC-LIKE ACTIVITY

      JOURNAL OF PSYCHOPHARMACOLOGY
    74. BELL R; HOBSON H
      5-HT1A RECEPTOR INFLUENCES ON RODENT SOCIAL AND AGONISTIC BEHAVIOR - A REVIEW AND EMPIRICAL-STUDY

      Neuroscience and biobehavioral reviews
    75. QUARTERMAIN D; CLEMENTE J; SHEMER A
      THE 5-HT1A AGONIST TANDOSPIRONE DISRUPTS RETENTION BUT NOT ACQUISITION OF ACTIVE-AVOIDANCE LEARNING

      Pharmacology, biochemistry and behavior
    76. CHARRIER D; DANGOUMAU L; HAMON M; PUECH AJ; THIEBOT MH
      EFFECTS OF 5-HT1A RECEPTOR LIGANDS ON A SAFETY SIGNAL WITHDRAWAL PROCEDURE OF CONFLICT IN THE RAT

      Pharmacology, biochemistry and behavior
    77. FRANKMANN SP; BRODER L; DOKKO JH; SMITH GP
      DIFFERENTIAL CHANGES IN CENTRAL MONOAMINERGIC METABOLISM DURING FIRSTAND MULTIPLE SODIUM DEPLETIONS IN RATS

      Pharmacology, biochemistry and behavior
    78. ROUAHROSILIO M; OROSCO M; NICOLAIDIS S
      SEROTONINERGIC MODULATION OF SODIUM APPETITE IN THE RAT

      Physiology & behavior
    79. CHAOULOFF F
      EFFECTS OF REPEATED 2-DEOXY-D-GLUCOSE ADMINISTRATION ON INGESTIVE, PSYCHOLOGICAL, AND 5-HT-RELATED BEHAVIORS IN THE RAT

      Neuropharmacology
    80. CAO BJ; LI WP
      BUSPIRONE AND 1-(2-PYRIMIDINYL)-PIPERAZINE ATTENUATE XYLAZINE-INDUCEDANTINOCICEPTION IN THE MOUSE

      Journal of Pharmacy and Pharmacology
    81. STJERNLOF P; ELEBRING T; NILSSON J; ANDERSSON B; LAGERKVIST S; SVENSSON K; EKMAN A; CARLSSON A; WIKSTROM H
      9-TETRAHYDRO-N,N-DI-N-PROPYL-3H-BENZINDOL-8-AMINES - DERIVATIVES AS POTENT AND ORALLY-ACTIVE SEROTONIN 5-HT1A RECEPTOR AGONISTS

      Journal of medicinal chemistry
    82. CAO BJ; LI WP
      ANTAGONISM OF CLONIDINE ANTINOCICEPTION BY BUSPIRONE AND 1-(2-PYRIMIDINYL)-PIPERAZINE

      European journal of pharmacology
    83. MCBLANE JW; HANDLEY SL
      EFFECTS OF 2 STRESSORS ON BEHAVIOR IN THE ELEVATED X-MAZE - PRELIMINARY INVESTIGATION OF THEIR INTERACTION WITH 8-OH-DPAT

      Psychopharmacology
    84. SHEPHERD JK; GREWAL SS; FLETCHER A; BILL DJ; DOURISH CT
      BEHAVIORAL AND PHARMACOLOGICAL CHARACTERIZATION OF THE ELEVATED ZERO-MAZE AS AN ANIMAL-MODEL OF ANXIETY

      Psychopharmacology
    85. HANDLEY SL; MCBLANE JW
      AN ASSESSMENT OF THE ELEVATED X-MAZE FOR STUDYING ANXIETY AND ANXIETY-MODULATING DRUGS

      Journal of pharmacological and toxicological methods
    86. SCHREIBER R; DEVRY J
      NEUROANATOMICAL BASIS FOR THE ANTIDEPRESSANT-LIKE EFFECTS OF THE 5-HT1A RECEPTOR AGONISTS 8-OH-DPAT AND IPSAPIRONE IN THE RAT FORCED SWIMMING TEST

      Behavioural pharmacology
    87. GRIEBEL G; BELZUNG C; MISSLIN R; VOGEL E
      THE FREE-EXPLORATORY PARADIGM - AN EFFECTIVE METHOD FOR MEASURING NEOPHOBIC BEHAVIOR IN MICE AND TESTING POTENTIAL NEOPHOBIA-REDUCING DRUGS

      Behavioural pharmacology
    88. ANSSEAU M; PITCHOT W; MORENO AG; WAUTHY J; PAPART P
      PILOT-STUDY OF FLESINOXAN, A 5-HT1A AGONIST, IN MAJOR DEPRESSION - EFFECTS ON SLEEP REM LATENCY AND BODY-TEMPERATURE

      Human psychopharmacology
    89. BOYER WF; FEIGHNER JP
      A PLACEBO-CONTROLLED DOUBLE-BLIND MULTICENTER TRIAL OF 2 DOSES OF IPSAPIRONE VERSUS DIAZEPAM IN GENERALIZED ANXIETY DISORDER

      International clinical psychopharmacology
    90. HANDLEY SL; MCBLANE JW; CRITCHLEY MAE; NJUNGE K
      MULTIPLE SEROTONIN MECHANISMS IN ANIMAL-MODELS OF ANXIETY - ENVIRONMENTAL, EMOTIONAL AND COGNITIVE-FACTORS

      Behavioural brain research
    91. NISHIMURA H; TANAKA M; TSUDA A; GONDOH Y
      ATYPICAL ANXIOLYTIC PROFILE OF BUSPIRONE AND A RELATED DRUG, SM-3997,IN A MODIFIED FORCED SWIM TEST EMPLOYING STRAW SUSPENSION

      Pharmacology, biochemistry and behavior
    92. COOPER SJ; CICCOCIOPPO R
      EFFECTS OF SELECTIVE 5-HT(1) RECEPTOR AGONISTS IN WATER-DEPRIVED RATSON SALT INTAKE IN 2-CHOICE TESTS

      Pharmacology, biochemistry and behavior
    93. COOPER SJ; BARBER DJ
      EFFECTS OF D-FENFLURAMINE, MK-212, AND ONDANSETRON ON SALINE DRINKINGIN 2-CHOICE TESTS IN THE REHYDRATING RAT

      Pharmacology, biochemistry and behavior
    94. SINGH A; LUCKI I
      ANTIDEPRESSANT-LIKE ACTIVITY OF COMPOUNDS WITH VARYING EFFICACY AT 5-HT(1A) RECEPTORS

      Neuropharmacology
    95. STEFANSKI R; PALEJKO W; BIDZINSKI A; KOSTOWSKI W; PLAZNIK A
      SEROTONERGIC INNERVATION OF THE HIPPOCAMPUS AND NUCLEUS-ACCUMBENS-SEPTI AND THE ANXIOLYTIC-LIKE ACTION OF MIDAZOLAM AND 5-HT(1A) RECEPTOR AGONISTS

      Neuropharmacology
    96. BENVENGA MJ; LEANDER JD
      ANTIDEPRESSANT-LIKE EFFECT OF LY228729 AS MEASURED IN THE RODENT FORCED SWIM PARADIGM

      European journal of pharmacology
    97. MOS J; OLIVIER B; POTH M; VANOORSCHOT R; VANAKEN H
      THE EFFECTS OF DORSAL RAPHE ADMINISTRATION OF ELTOPRAZINE, TFMPP AND 8-OH-DPAT ON RESIDENT INTRUDER AGGRESSION IN THE RAT

      European journal of pharmacology

    98. MODELS OF 5-HT(1A)-RECEPTOR FUNCTION

      Trends in pharmacological sciences
    99. FLETCHER PJ; MING ZH; HIGGINS GA
      CONDITIONED PLACE PREFERENCE INDUCED BY MICROINJECTION OF 8-OH-DPAT INTO THE DORSAL OR MEDIAN RAPHE NUCLEAS

      Psychopharmacology
    100. HANDLEY SL; MCBLANE JW
      5HT DRUGS IN ANIMAL-MODELS OF ANXIETY

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:31:13